Novexia Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -14.89%
- Profit Growth 15.34%
- Ebitda -167.90%
- Net Worth -86.57%
- Total Assets -20.42%
About Novexia Pharma
Novexia Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and four months 21 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akhilesh Maurya, Kunwar Singh, and Deepak Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018PTC339169
-
Company No.
339169
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Novexia Pharma Private Limited offer?
Novexia Pharma Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Cefixime Ofloxacin Tablets, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Antiemetic Drugs, Domperidone Tablet, Juices, Soups & Soft Drinks, Instant Drink Mix, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Novexia Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhilesh Maurya
|
Director | 07-Jan-2022 | Current |
|
Kunwar Singh
|
Director | 19-Jan-2024 | Current |
|
Deepak Kumar
|
Director | 19-Jan-2024 | Current |
Financial Performance of Novexia Pharma.
Novexia Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.89% decrease. The company also saw a substantial improvement in profitability, with a 15.34% increase in profit. The company's net worth observed a substantial decline by a decrease of 86.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novexia Pharma?
Unlock access to Novexia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Helistra Healthcare Private LimitedAkhilesh Maurya is a mutual person
-
R L Polymers Private Limited
Akhilesh Maurya is a mutual person
-
Genoviq Lifesciences Private Limited
Kunwar Singh and Deepak Kumar are mutual person
-
Neopulse Lifesciences Private Limited
Kunwar Singh and Deepak Kumar are mutual person
-
Genoviq Healthcare Private Limited
Kunwar Singh and Deepak Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novexia Pharma?
Unlock and access historical data on people associated with Novexia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novexia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novexia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
